Medical Director or Senior Medical Director

Role: Lead clinical development for the STAT6 program at a biopharma focused on targeted protein degradation (TPD). Responsibilities include designing and executing clinical studies, integrating translational and biomarker data to refine patient selection and endpoints, providing medical oversight during trials, and collaborating with external partners and academic institutions. The role also involves contributing to regulatory documentation, leading cross-functional teams, and representing the company in scientific and regulatory forums. Requirements: MD or MD/PhD with at least 4 years of clinical drug development experience, including 2+ years in dermatology-related programs or with dermatologic endpoints; proven expertise in Phase I–III trials, regulatory interactions, and biomarker science. Preferred skills include experience with global regulatory agencies (FDA, EMA), translational science, and mechanistic drug development. High-value specifics: focus on dermatologic indications, early to late-phase clinical trials, and biomarker integration within innovative TPD therapies. The position entails leadership in a fast-paced, collaborative environment with opportunities to influence novel oral small molecule degraders. Work setup details are not specified, but the role emphasizes cross-functional and external stakeholder engagement.